Targeted radiation therapy trial offers new hope for Tough-to-Treat gut and pancreas tumors
Disease control
Ongoing
This study is comparing a newer, targeted radiation treatment called PRRT against the current best standard care for patients with aggressive neuroendocrine tumors in the digestive system or pancreas. It aims to see if the targeted therapy can better control tumor growth, improve…
Phase: PHASE3 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC